Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03130608
Other study ID # 20170229
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 30, 2017
Est. completion date May 31, 2021

Study information

Verified date June 2021
Source University of Miami
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Individuals with chronic liver disease develop significant muscle wasting that remains post-liver transplant. The transplant surgery additionally challenges respiratory mechanics. Respiratory muscle strength has been measured to be impaired in individuals post liver transplant. This study proposes an 8 week intervention designed to increase respiratory muscle strength and pulmonary function that we hypothesize will correlate to improved functional performance and quality of life post-liver transplant. Pre-test post-test design, that will randomize subjects into an experimental group that will receive the inspiratory muscle strengthening exercise in addition to usual post-liver transplant care and a control group that will only receive the usual post-transplant care. Up to 50 subjects will be recruited from the Post-Liver Transplant Outpatient Clinic at the Miami Transplant Institute. The subjects will have repeated measurements of respiratory muscle strength, pulmonary function, functional mobility performance, and quality of life at baseline, 4 weeks, and 8 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 37
Est. completion date May 31, 2021
Est. primary completion date May 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Subjects must have undergone liver transplantation for chronic liver disease of any origin other than cancer. Exclusion Criteria: 1. Severe cardiopulmonary disease such as recent Myocardial infarction, Congestive Heart Failure, Pulmonary edema, Chronic Obstructive Pulmonary Disease, and Asthma, 2. Severe osteoarthritis 3. Blindness 4. Wheelchair bound individuals 5. Individuals with neurological / neuromuscular disorders including but not limited to: cerebral vascular accident, Parkinsonism, Alzheimer's disease, dystonia, multiple sclerosis, and polio. 6. Severe Cognitive impairment where individuals cannot follow commands and are unable to sign informed consent -

Study Design


Intervention

Other:
Inspiratory Muscle Training
Subjects will breath through a hand held valve that has adjustable resistance to strengthen the muscles used for breathing. Subjects will perform the exercise approximately 20-30 minutes, twice a day for 8 weeks.

Locations

Country Name City State
United States Miami Transplant Institute Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline Maximal Inspiratory Pressure (MIP) at 4 weeks and 8 weeks. MIP is a measure of inspiratory muscle strength . Inspiratory testing will be performed using a Micro Mouth Pressure Manometer. 92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing.
Each measurement will be performed 3 times with the maximal score recorded.
Baseline, 4 weeks, and 8 weeks.
Primary Change from baseline Forced Expiratory Volume (FEV1) at 4 weeks and 8 weeks FEV1 is how much air can be exhaled during a forced exhalation at one second. Inspiratory testing will be performed using a Micro Mouth Pressure Manometer. 92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing.
Each measurement will be performed 3 times with the maximal score recorded.
Baseline, 4th week, and 8th week
Primary Change from baseline 6 Minute Walk Distance at 4 weeks and 8 weeks. In a 100ft. straight hallway the subject will walk back and forth, from one end to the other, as many times as they can in 6 minutes. The subject will have the option to rest at any time during the six minutes. The clock will keep running whether the subject is walking or resting. The subject will be provided standardized cues to prevent unequal encouragement. The distance walked over the 6 minutes will be recorded. Throughout the walking test, the investigator will be walking nearby to guard patient from loss of balance or fall. Baseline, 4 weeks, and 8 weeks
Primary Change from baseline 30 Second Chair Stand Repetitions at 4 weeks and 8 weeks. From a straight back chair the subject will come to a complete stand and then return to sitting with arms across chest. The number of times the subject can stand in 30 seconds will be recorded. The investigator will be standing nearby guarding the subject to protect from any loss of balance or fall. Baseline, 4 weeks, and 8 weeks
Primary Change from baseline Chronic Liver Disease Questionnaire (CLDQ) Score at 4 weeks and 8 weeks. This is a paper and pencil questionnaire consisting of 29 items in 6 domains: 1) Abdominal Symptoms 2) Activity: eating habits and movement of heavy objects 3) Emotional Function 4) Fatigue: perception of decreased energy and sleepiness 5) Systemic symptoms 6) Worry: concerns regarding disease progression and family. Summary scores for each domain range from 1(most impaired) to 7 (least impaired). All items refer to the previous 2 weeks. Higher scores indicate less impairment. Baseline, 4 weeks, and 8 weeks
Primary Change from baseline Karnovsky Performance Status Score at 4 weeks and 8 weeks. This is a paper pencil questionnaire measuring functional impairment. The questionnaire is divided into three groups for classifying patient's ability to work, to carry on normal activity, and to care for themselves. The groups are further divided into eleven categories covering all level so functioning from normal (100) to dead (0). The lower the Karnovsky score, the worse the functional ability and survival for most serious illness. The liver transplant team records this measure prior to transplant. We will obtained pre-transplant scores from medical record for use in correlational analysis. This measure will also performed at baseline and post-testing. Baseline, 4 weeks, and 8 weeks
Primary Change from baseline Sustained Maximal Inspiratory Pressure (SMIP) at 4 weeks and 8 weeks. SMIP will be measured from residual volume to total lung capacity representing single breath work/endurance. Inspiratory testing will be performed using a Micro Mouth Pressure Manometer. 92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Baseline, 4 weeks, and 8 weeks
Primary Change from baseline Inspiratory Duration (ID) at 4 weeks and 8 weeks ID is the inspiratory flow during maximal inspiration effort with an isokinetic like resistance from the mouthpiece. Inspiratory testing will be performed using a Micro Mouth Pressure Manometer. 92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Baseline, 4 weeks, and 8 weeks
Primary Change from baseline Maximal Expiratory Pressure (MEP) at 4 weeks and 8 weeks. MEP is a measure of expiratory muscle strength measured from total lung capacity. Inspiratory testing will be performed using a Micro Mouth Pressure Manometer. 92887) Measurements will be performed in the testing position with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing. Baseline, 4 weeks, and 8 weeks
Primary Change from baseline Forced Vital Capacity (FVC) at 4 weeks and 8 weeks. FVC is the total amount of air exhaled during a pulmonary function test. Expiratory testing will be performed using the Jones Satellite Spirometer (Jones Medical Instrument Company, Oakbrook, Illinois 65021) Measurements will be performed in the manner described using American Thoracic Society guidelines with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing.
Each measurement will be performed 3 times with the maximal score recorded.
Baseline, 4 weeks, 8 weeks.
Primary Change from baseline Forced Expiratory Flow (FEF25-75%) at 4weeks and 8 weeks. FEF25-75% is the flow rate at 25% to 75% of Forced Vital Capacity. Expiratory testing will be performed using the Jones Satellite Spirometer (Jones Medical Instrument Company, Oakbrook, Illinois 65021) Measurements will be performed in the manner described using American Thoracic Society guidelines with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing.
Each measurement will be performed 3 times with the maximal score recorded.
Baseline, 4 weeks, 8 weeks.
Primary Change from baseline Peak Expiratory Flow Rate (PEFR) at 4weeks and 8 weeks. PEFR is a measure of how fast a person can exhale. Expiratory testing will be performed using the Jones Satellite Spirometer (Jones Medical Instrument Company, Oakbrook, Illinois 65021) Measurements will be performed in the manner described using American Thoracic Society guidelines with subjects in the seated position and the trunk at a 90 degree angle to the hips. Subjects will wear a nose clip during testing.
Each measurement will be performed 3 times with the maximal score recorded.
Baseline, 4 weeks, 8 weeks.
See also
  Status Clinical Trial Phase
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Enrolling by invitation NCT03297632 - Improving Muscle Strength, Mass and Physical Function in Older Adults N/A
Completed NCT04207359 - Effects of Creatine Supplementation in Breast Cancer Survivors N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT04076982 - Effect of Supplementary Dietary Protein (21g Per Day) on Lean Mass and Strength in Sedentary, Adult Vegetarians N/A
Not yet recruiting NCT03662555 - Effect of Neuromuscular Electrical Stimulation Combined With Blood Flow Restriction on Muscular and Cardiovascular Function N/A
Completed NCT02530723 - Functional Changes and Power Training in Older Women. N/A
Completed NCT01743495 - CAPABLE for Frail Dually Eligible Older Adults N/A
Completed NCT01704976 - SR-WBV Training for Frail Elderly in the Skilling up Stage N/A
Completed NCT00183040 - HORMA: Hormonal Regulators of Muscle and Metabolism in Aging Phase 2
Enrolling by invitation NCT06432062 - Investigation the Effect of Rectus Abdominis and Erector Spinae Muscle Fatigue on the Viscoelastic Properties of Thoracolumbal Fascia
Recruiting NCT05073224 - Muscle Function After Childbirth N/A
Completed NCT04956705 - Vitamin D and Calcium Supplementation at Danish Nursing Homes N/A
Recruiting NCT03810768 - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Completed NCT00060970 - Evaluating Muscle Function After Ankle Surgery N/A
Completed NCT04546048 - The Early Strength Training Program in Post-transplant Liver Cases N/A
Completed NCT03628365 - Can Beta-Hydroxy-beta-Methylbutyrate Supplementation Counteract Muscle Catabolism in Critically Ill Patients? N/A
Completed NCT05056298 - Effect of Insole Added to Exercise in Patients With Bilateral Flexible Flatfoot N/A
Completed NCT02739464 - Effect of In-Patient Exercise Training on Length of Hospitalization in Burned Patients N/A
Completed NCT05497960 - Vivo Prediabetes Study: Online, Live, and Interactive Strength Training for Older Adults With Prediabetes N/A